197 related articles for article (PubMed ID: 23527106)
1. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
[TBL] [Abstract][Full Text] [Related]
2. Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease.
Hyttinen V; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Valtonen H
Ann Pharmacother; 2017 Sep; 51(9):725-734. PubMed ID: 28486815
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.
Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2017 Dec; 32(12):e107-e115. PubMed ID: 28055139
[TBL] [Abstract][Full Text] [Related]
4. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
[TBL] [Abstract][Full Text] [Related]
5. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
[TBL] [Abstract][Full Text] [Related]
6. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease.
Lintula E; Tiihonen M; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Hamina A
Drugs Aging; 2020 Mar; 37(3):193-203. PubMed ID: 31879863
[TBL] [Abstract][Full Text] [Related]
7. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort.
Tolppanen AM; Kettunen R; Ahonen R; Soininen H; Hartikainen S
Int J Cardiol; 2013 Dec; 170(2):195-201. PubMed ID: 24200309
[TBL] [Abstract][Full Text] [Related]
8. Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study.
Taipale H; Hamina A; Karttunen N; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
Pain; 2019 Feb; 160(2):417-423. PubMed ID: 30325873
[TBL] [Abstract][Full Text] [Related]
9. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
10. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
12. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
14. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
15. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
Rajamaki B; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
[TBL] [Abstract][Full Text] [Related]
16. Incidence of stroke in people with Alzheimer disease: a national register-based approach.
Tolppanen AM; Lavikainen P; Solomon A; Kivipelto M; Soininen H; Hartikainen S
Neurology; 2013 Jan; 80(4):353-8. PubMed ID: 23284063
[TBL] [Abstract][Full Text] [Related]
17. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
[TBL] [Abstract][Full Text] [Related]
18. Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer's disease: a matched cohort study.
Rajamaki B; Koponen M; Hartikainen S; Tolppanen AM
BMC Geriatr; 2020 Jun; 20(1):214. PubMed ID: 32552688
[TBL] [Abstract][Full Text] [Related]
19. Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer's Disease: A Cohort Study in Finland.
Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2184-2192. PubMed ID: 32797165
[TBL] [Abstract][Full Text] [Related]
20. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.
Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur J Pain; 2017 Apr; 21(4):658-667. PubMed ID: 27862681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
